Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
169.84
+1.88 (1.12%)
Apr 3, 2025, 1:45 PM EDT - Market open
Quest Diagnostics Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Quest Diagnostics stock have an average target of 179.57, with a low estimate of 165 and a high estimate of 195. The average target predicts an increase of 5.73% from the current stock price of 169.84.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Quest Diagnostics stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 4 | 4 | 4 | 2 | 3 |
Buy | 2 | 3 | 4 | 4 | 4 | 4 |
Hold | 8 | 7 | 6 | 6 | 7 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 13 | 14 | 14 | 14 | 13 | 14 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Redburn Atlantic | Redburn Atlantic | Strong Buy Initiates $195 | Strong Buy | Initiates | $195 | +14.81% | Apr 2, 2025 |
Baird | Baird | Buy Maintains $190 → $191 | Buy | Maintains | $190 → $191 | +12.46% | Mar 20, 2025 |
Citigroup | Citigroup | Strong Buy → Hold Downgrades $185 | Strong Buy → Hold | Downgrades | $185 | +8.93% | Mar 4, 2025 |
JP Morgan | JP Morgan | Hold Maintains $173 → $180 | Hold | Maintains | $173 → $180 | +5.98% | Feb 4, 2025 |
Mizuho | Mizuho | Buy Maintains $177 → $178 | Buy | Maintains | $177 → $178 | +4.80% | Feb 3, 2025 |
Financial Forecast
Revenue This Year
10.89B
from 9.87B
Increased by 10.28%
Revenue Next Year
11.31B
from 10.89B
Increased by 3.91%
EPS This Year
9.79
from 7.69
Increased by 27.26%
EPS Next Year
10.71
from 9.79
Increased by 9.40%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 11.4B | 12.0B | 12.6B | |
Avg | 10.9B | 11.3B | 11.7B | |
Low | 10.5B | 10.9B | 11.1B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 15.2% | 10.4% | 11.1% | |
Avg | 10.3% | 3.9% | 3.8% | |
Low | 6.2% | -0.3% | -1.9% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 10.24 | 12.45 | 13.30 | ||
Avg | 9.79 | 10.71 | 11.60 | ||
Low | 9.46 | 10.02 | 10.83 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 33.1% | 27.3% | 24.3% | ||
Avg | 27.3% | 9.4% | 8.4% | ||
Low | 23.0% | 2.3% | 1.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.